共 50 条
- [21] ADRIAMYCIN (NSC-123127) PLUS 5-FLUOROURACIL (NSC-19893) - PHASE-1 STUDY CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (06): : 1163 - 1165
- [22] ADRIAMYCIN (NSC-123127) VERSUS 5-FLUOROURACIL (NSC-19893) AND CYCLOPHOSPHAMIDE (NSC-26271) IN TREATMENT OF METASTATIC PROSTATE CANCER CANCER TREATMENT REPORTS, 1976, 60 (01): : 115 - 117
- [23] COMBINATION CHEMOTHERAPY WITH ADRIAMYCIN (NSC-123127) AND CYCLOPHOSPHAMIDE (NSC-26271) FOR SOLID TUMORS - PHASE-2 TRIAL CANCER TREATMENT REPORTS, 1976, 60 (01): : 77 - 83
- [25] COMPARISON OF DAUNORUBICIN (NSC-83142) WITH ADRIAMYCIN (NSC-123127) IN TREATMENT OF LATE-STAGE CHILDHOOD SOLID TUMORS CANCER CHEMOTHERAPY REPORTS PART 1, 1974, 58 (05): : 671 - 676
- [26] PHASE-II EVALUATION OF BISANTRENE IN METASTATIC BREAST-CANCER CANCER TREATMENT REPORTS, 1985, 69 (03): : 337 - 338
- [27] ADRIAMYCIN (NSC-123127) IN TREATMENT OF ALKYLATOR-RESISTANT MULTIPLE-MYELOMA - PILOT-STUDY CANCER CHEMOTHERAPY REPORTS PART 1, 1975, 59 (02): : 345 - 350
- [28] RANDOMIZED PHASE-II TRIAL OF RUBIDAZONE AND ADRIAMYCIN IN WOMEN WITH ADVANCED BREAST-CANCER CANCER TREATMENT REPORTS, 1979, 63 (11-1): : 1701 - 1705
- [29] PHASE 2 TRIAL OF 5-FLUOROURACIL (NSC-19893), ADRIAMYCIN (NSC-123127), AND METHOTREXATE (NSC-740) IN LUNG ADENOCARCINOMA CANCER TREATMENT REPORTS, 1976, 60 (05): : 623 - 624